Proof-of-concept study using dinutuximab and activated natural killer cells leads to a clinical trial
Neuroblastoma, a disease of immature nerve cells, is the most common solid tumor cancer occurring in children. About 700 new cases are diagnosed in the U.S. each year with approximately half of these children developing high-risk ...
Oct 4, 2018
0
0